Multispecialty - Abbvie
Multispecialty
Status:
EnrollingClinicalTrials.gov:
NCT05843643A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE
A Phase 3 Program to Evaluate the Safety and Efficacy of Upadacitinib in Subjects with Moderately to Severely Active SLE